Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001)Masayoshi Miyawaki, Kenzo Soejima, Ryosuke Satomi et al.|Molecular and Clinical Oncology|2017Cited by 10
Factors associated with improvements in subjective symptoms of obstructive sleep apnea syndrome after continuous positive airway pressure therapyKengo Otsuka, Tomoko Betsuyaku, Koichi Fukunaga et al.|Sleep And Breathing|2019Cited by 4